Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
(199 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Appendix_cancer]] | |||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
appendix cancer must be differentiated from | [[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]]. | ||
==Differentiating appendix cancer from other Diseases== | |||
*[[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]]. | |||
*As [[appendix cancer]] manifests in a variety of [[clinical]] forms, differentiation must be established in accordance with the particular subtype. | |||
:*[[Carcinoid Tumor|Carcinoid tumors]] must be differentiated from other diseases that cause [[carcinoid syndrome]] sign and symptoms such as [[palpitation]], [[Flushing|facial flushing]], and [[diarrhea]]. | |||
:*In contrast, [[adenocarcinoma]]<nowiki/>s and cystadenocarcinomas must be differentiated from other diseases that cause [[Appendicitis|acute appendicitis]] or present with [[pseudomyxoma peritonei]], such as [[Colorectal cancer|colorectal cancers]] and [[Appendix cancer echocardiography and ultrasound|appendix mucoceles]]. | |||
<small> | |||
{| class="wikitable" | |||
|- | |||
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | |||
| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | |||
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | |||
|- | |||
| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | |||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | |||
|- | |||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | |||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | |||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | |||
pathology | |||
|- | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | |||
freq- | |||
uency | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | |||
'''symptoms''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
physical | |||
exami- | |||
nation | |||
findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | |||
sounography | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
diagnostic | |||
studies | |||
and | |||
imaging | |||
modalities | |||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenocarcinoma|Adeno-]] | |||
[[Adenocarcinoma|carcinoma]]<small><sup>1</sup></small> | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adenocarcinoma<small><sup>1</sup></small> | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | -/+ | | style="background: #F5F5F5; padding: 5px;" | -/+ | ||
| style="background: #F5F5F5; padding: 5px;" | | style="background: #F5F5F5; padding: 5px;" | <math>\downarrow</math> | ||
|< | | rowspan="1" style="background: #F5F5F5; padding: 5px;" | | ||
| | * '''Generally [[Asymptomatic|asympto-<br>matic]]''' | ||
* '''Generally | * [[Appendicitis]] [[Symptom|symptoms]] | ||
* Appendicitis symptoms | * [[Nausea and vomiting|Nausea<br>&<br>vomiting]],<br>decreased<br>[[appetite]] | ||
* [[Nausea and vomiting|Nausea & vomiting]],[[ | * No gas<br>or<br>stool pass<br>([[Bowel obstruction|intestinal<br>obstruction]]) | ||
* No gas or stool pass (intestinal obstruction) | * [[Bone pain]]<br>(bone<br>[[Metastasis|metastasis)]] | ||
* Bone pain (bone metastasis) | * [[Bloating]]<br>([[ascites]]) | ||
* Bloating (ascites) | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
* | * | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Soft tissue thickening | * Soft<br>tissue<br>thickening | ||
* Wall irregularity | * Wall<br> irregularity | ||
* Presence of | * Presence<br>of<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br>peritonei]] | ||
* Calcification | * [[Calcification]] | ||
* Internal septations | * Internal<br>septations | ||
* | * Peri<br>appendiceal<br>fat<br>stranding<br>and<br>intra-<br>peritoneal<br>free fluid<br> which is a<br> nonspecific<br> finding | ||
* Cystic lesion | * Cystic<br> lesion | ||
* | * | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Diffusion weighted MRI has been shown to be the modality of choice for peritoneal | * Diffusion<br>weighted<br>[[Magnetic resonance imaging|MRI]]<br>has<br>been<br>shown to<br>be<br>the<br>modality<br>of choice<br>for<br>''[[Peritoneal carcinomatosis|peritoneal<br>carcino-<br>matosis]]'' | ||
* Increased fluid signal on T2 weighted sequence | * Increased<br>fluid<br>signal on<br>T2 weighted sequence | ||
* Soft tissue mass in the [[appendix]] | * Soft<br> tissue<br> mass in<br> the<br>[[appendix]] | ||
* Invasion to other structures | * Invasion to<br>the other<br>structures | ||
| rowspan="2" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Dilated appendix | * Dilated<br>appendix | ||
* | * Peri-<br>appendiceal<br> fluid<br> collection | ||
* Distinct appendix wall layers | * Distinct<br> appendix<br> wall<br> layers | ||
| style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography]] (PET) | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|Positron<br>emission<br>tomography]]<br>(PET) | ||
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''': | | style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''': | ||
* Gray/ | * Gray/yellow<br>color | ||
* Cystic structures with angiolymphatic invasion | * Cystic<br>structures<br>with<br>angiolymphatic<br>invasion | ||
'''Microscopic pathology:''' | * [[Vermiform appendix|Appendix]]<br>might be<br>buried<br>within<br>the mass | ||
'''Microscopic<br>pathology:''' | |||
| | * Intestinal,<br>mucinous<br>or<br>[[Signet ring cell carcinoma|signet ring<br>cell]] types | ||
* Coexisting<br>[[Appendicitis|acute<br>appendicitis]]<br>is common | |||
'''[[Immunohistochemistry|IHC]]:''' | |||
* MUC 2 | |||
* '''MUC5AC''' | |||
* CK 8/18 | |||
* CK 13 | |||
* CK 19 | |||
* CK 20 | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid tumor<sup>2</sup> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carcinoid Tumor|Carcinoid]] | ||
[[Carcinoid Tumor|tumor]]<sup>2</sup> | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | ||
|< | | rowspan="1" style="background: #F5F5F5; padding: 5px;" | | ||
| | * '''Generally [[Asymptomatic|asympto-<br>matic]]''' | ||
* '''Generally | * [[Flushing]] | ||
* Flushing | * [[Palpitation]] | ||
* Palpitation | * [[Dyspnea]] | ||
* Dyspnea | |||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Tricuspid regurgitation | * [[Tricuspid regurgitation|TR]]<br>[[Heart murmur|murmur]] | ||
* | * [[Wheeze|Wheezing]] | ||
* | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
Ki67:<br>a reliable<br>marker of<br>cell<br>proliferation | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* [[Somatostatin]]<br>[[scintigraphy]]<br>with<br> 111-indium-<br>octreotide | |||
* [[Bone]]<br>[[scintigraphy]]<br> with<br> 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP) | |||
* Positron<br>emission<br>tomography<br>(PET) | |||
| style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''': | |||
* [[Prevalence|Prevalent]]<br>at the<br>tip of<br>[[Vermiform appendix|appendix]] | |||
* Generally<br>less than<br>1 cm | |||
* Gray or <br>yellow | |||
* Well-<br>demarcated<br>firm | |||
* Intramural<br>nodules<br>that may<br>narrow or<br>obliterate<br>appendiceal<br> lumen | |||
* Proximal<br>tumors<br>may cause<br>obstruction<br>and<br>appendicitis | |||
'''Microscopic<br>pathology:''' | |||
*Insular<br>growth<br>pattern<br>of solid<br>islands of<br>uniform<br>polygonal<br>cells with<br>minimal<br>pleomorphism | |||
*Retraction<br>of<br>peripheral<br>tumor<br>cells from<br> stroma | |||
*Angio-<br>lymphatic<br>invasion<br>is common | |||
*Granular<br>eosinophilic<br>cytoplasm<br>with either<br>diffusely<br>scattered<br>or<br>peripherally<br>clumped<br>granules | |||
*Two types<br>of well<br>differentiated<br>tumors:<br> EC cell <br>(serotonin<br> producing) <br>and rarely<br> L-cell<br> (enteroglucagon<br>or <br>peptide YY <br>producing) | |||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
*Might be<br> positive for <br>'''S100''' | |||
|- | |||
| style="background: #DCDCDC; padding: 5px;" |Goblet | |||
cell | |||
carcinoid | |||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* '''Generally asympto-<br>matic''' | |||
* 60% present<br>with [[acute appendicitis]] symptoms | |||
* [[Nausea and vomiting|Nausea<br>&<br>vomiting]] | |||
* [[decreased appetite]]<br>(anorexia) | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * [[Ascites]] | ||
* Shifting<br>dullness | |||
* May<br>appear<br>anemic | |||
* | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* '''CK 20''' | |||
* '''CK 7''' | |||
* [[Synapthosin|Synap- thosin]] | |||
* pancreatic polypeptide | |||
* [[CEA]] | |||
* [[CA 19-9]] | |||
* [[CA-125|CA -125]] | |||
| colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately,<br> compared to the other carcinoid tumors of appendix,<br> GCC is more aggressive and <br>patients with GCC generally present at higher stages.<br> Hence, in addition to<br> the above mentioned <br>general findings for appendix cancers, <br>imaging studies should <br>look for evidences of peritoneal involvement,<br> bone metastasis, lymphadenopathy, <br>and metastatic lesions<br> in ovaries and/or prostate. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | '''Gross<br>pathology''': | ||
* | * No gross<br>tumor might<br>be present | ||
* | * Thickened<br>appendiceal<br>wall | ||
|''' | '''Microscopic<br>appearance:''' | ||
*GCC Generally<br>spares mucosa<br>and<br>infiltrates<br>muscularis<br>propria<br>and<br>peri-<br>appendiceal<br> fat | |||
*Tumor<br> cell clusters | |||
*Crypt-like<br> structures | |||
*Tubules of<br> mucus-secreting <br>cells distended<br> with mucin <br>resembling<br> goblet cells | |||
*Eosinophilic<br> cytoplasm <br>resembling<br> carcinoid <br>tumors | |||
*Pools of <br>extracellular<br> mucin | |||
*Scattered<br>Paneth cells<br>in tumors<br>with crypt<br>like<br>structures | |||
*Extensive<br>perineural<br>invasion | |||
*'''Carcinomatous<br>growth<br>pattern:''' | |||
*Cribriform<br>growth<br>pattern,<br>solid<br>sheets of<br>infiltrating<br>signet ring<br>cells | |||
*Nuclear<br>pleomorphism | |||
*Increased<br>mitotic<br>activity | |||
|- | |||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | |||
freq- | |||
* | uency | ||
''' | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ||
|[[ | '''symptoms''' | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br>tender-<br>ness | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
physical | |||
exami- | |||
nation | |||
findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | |||
sounography | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
diagnostic | |||
studies | |||
and | |||
imaging | |||
modalities | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | |||
pathology | |||
|- | |||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | |||
| style="background: #DCDCDC; padding: 5px;" |Mucosal | |||
[[hyperplasia]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | |||
* '''Generally asympto-<br>matic''' | |||
* Benign<br>even<br>after<br>rupture | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" row span="2" |N/A | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |N/A | |||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | | |||
* | |||
* low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum | |||
* [[Inflammation]]<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele | |||
* Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele | |||
* Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup> | |||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | [https://radiopaedia.org/articles/appendiceal-mucocele-2 Rounded<br>right iliac<br> fossa mass] | |||
*'''T1:''' The<br>signal<br> depends<br> on <br> the mucin<br> concen-<br> tration,<br> may be<br> from<br> hypointense<br> to<br> isointense | |||
*'''T2:'''<br> Hyperintense | |||
* | |||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | | |||
* Histo-<br>logically<br>benign | |||
* Dilated<br>fluid<br>filled<br>appendix<br>in the<br>RLQ. | |||
* Thin<br>appendiceal<br>wall | |||
* A focus<br>of<br>hyper-<br>echogenicity | |||
* '''Since<br> generally<br> there is<br> no [[inflammation]]''' | |||
* Surrounding <br>fat<br> is normal. | |||
* No peri-<br>appendiceal <br>fluid or<br>collection | |||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A | |||
| style="background: #F5F5F5; padding: 5px;" |Similar<br>to<br>hyperplastic<br>colon<br>polyp | |||
|- | |||
| style="background: #DCDCDC; padding: 5px;" |Simple | |||
or | |||
[[Mucous retention cyst|retention]] | |||
[[Mucous retention cyst|cyst]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |N/A | |||
| style="background: #F5F5F5; padding: 5px;" |Degenerative<br>epithelial<br>changes<br>because of<br>obstruction | |||
|- | |||
| style="background: #DCDCDC; padding: 5px;" | Mucinous cyst- | |||
adenomas | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* '''Generally asympto-<br>matic''' | |||
* Rupture<br>may<br>lead<br>to<br>Pseudo-<br>myxoma<br>peritonei | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | |||
[[Pseudomyxoma peritonei|pseudo-<br>myxoma<br> peritonei]]:<br> | |||
* [[Ascites]] | |||
* [[Shifting dullness|Shifting<br>dullness]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* [[CEA]] | |||
* [[CA 19-9]] | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Histo-<br>logically<br>benign | |||
* Similar<br>to<br>colon<br>adenomatous<br>polyps or<br> villous <br>adnomas | |||
|- | |- | ||
| colspan="2" |[[Ovarian cancer differential diagnosis|Ovarian cancer]] | | style="background: #DCDCDC; padding: 5px;" | Mucinous [[Cystadenocarcinoma staging|cystadeno-]] | ||
[[Cystadenocarcinoma staging|carcinomas]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* [[CEA]] | |||
* [[CA 19-9]] | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Glandular<br>invasion<br>into the<br>stoma | |||
* Pseudo-<br>myxoma<br>peritonei | |||
|- | |||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel<br>freq-<br>uency | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | |||
'''symptoms''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
physical<br>exami-<br>nation<br>findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-<br>sounography<br> | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other<br>diagnostic<br>studies<br>and<br>imaging<br>modalities<br> | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | |||
pathology | |||
|- | |||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]] | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | ||
|<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" | | ||
| | * Pelvic/ [[abdominal pain]] or pressure | ||
* Pelvic/abdominal pain or pressure | * [[Vaginal bleeding]]/ discharge | ||
* Vaginal bleeding/discharge | * [[Dyspnea|Dyspne]]<nowiki/>a | ||
* Dyspnea | * GI disturbance | ||
* GI disturbance | |||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
* Fever | * [[Fever]] | ||
* Pleural effusion | * [[Pleural effusion]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''Depends on the underlying etiology''' | * '''Depends<br>on<br>the<br>underlying<br>etiology''' | ||
* Iron | * Iron | ||
* HCG | * [[Human chorionic gonadotropin|HCG]] | ||
* LDH | * [[Lactate dehydrogenase|LDH]] | ||
* Calcium | * [[Calcium]] | ||
* Estrogen | * [[Estrogen]] | ||
* | * Progestron | ||
* Testosterone | * [[Testosterone|Testos-<br>terone]] | ||
* AFP | * [[Alpha-fetoprotein|AFP]] | ||
* CA 125 | * [[CA-125]] | ||
* Ki 67 | * Ki 67 | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal mass | * Adnexal<br> mass | ||
* Adenexal Cyst (simple or complex) | * Adenexal <br> Cyst<br>(simple<br>or<br>complex) | ||
* Fluid accumulation | * Fluid <br>accumulation | ||
* Endometrial thickening | * Endometrial <br>thickening | ||
* | * Calcification | ||
* Pleural effusion | * Pleural <br>effusion | ||
* Peritoneal involvement | * Peritoneal<br>involvement | ||
* | * [[Lymphadenopathy|Lympha-denopathy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal mass | * Adnexal <br> mass | ||
* Adenexal | * Adenexal <br> cyst<br>(simple<br>or<br>complex) | ||
* Except for [[Thecoma]], ovarian masses are generally hyperintense on T1 and hypo or | * Except for<br>[[Thecoma]],<br>ovarian<br>masses <br>are <br>generally hyperintense <br>on T1 and<br>hypo or<br> sointense <br> on <br>T2 imaging | ||
* Fluid accumulation | * Fluid<br>accumulation | ||
* Endometrial thickening | * Endometrial<br>thickening | ||
* | * Calcification | ||
* Pleural effusion | * Pleural <br>effusion | ||
* Peritoneal involvement | * Peritoneal <br>involvement | ||
* | * Lympha-<br>denopathy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Adnexal <br>mass | ||
* Adenexal <br> cyst<br> (simple<br> or<br> complex) | |||
* Fluid <br>accumulation | |||
* Increased <br>[[Doppler ultrasound|Doppler]]<br> flow | |||
* Endometrial<br>thickening | |||
* Calcification | |||
| style="background: #F5F5F5; padding: 5px;" | N/A | |||
| style="background: #F5F5F5; padding: 5px;" | Depends<br>on the<br>tumor type.<br>You may<br>find the<br>details<br>[[Ovarian cancer differential diagnosis|here]]. | |||
|- | |- | ||
| colspan="2" | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|< | |||
| | |||
* [[Weight loss]] | * [[Weight loss]] | ||
* [[Fatigue]] | * [[Fatigue]] | ||
* Low caliber of stools | * Low caliber<br>of stools | ||
* | * Nausea<br>and<br>vomiting | ||
* [[Mucus]] in stools | * [[Mucus]] in<br>stools | ||
* [[Rectal prolapse]] | * [[Rectal prolapse]] | ||
* | * '''in Carcinoids:''' | ||
* | *''[[Weight gain|Weight<br>loss]]'' | ||
* | *''[[Weakness]]'' | ||
* | * ''[[Flushing (physiology)|Flushing]]'' | ||
* | * ''[[Wheezing]]'' | ||
* | * ''[[Shortness of breath]]'' | ||
* | * ''[[Palpitations]]'' | ||
* | *'' [[Leg edema]]'' | ||
|<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| | | style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | ||
|< | ''[[Adenocarcinoma|Adeno-]]'' | ||
|< | |||
| | ''[[Adenocarcinoma|carcinoma]]'' | ||
* [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous) | |||
* [[Ulcer|Ulcerating<br>polyps]] | |||
* [[Cancerous]]<br>[[lesions]] | |||
''Carcinoids'' | |||
* [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon | |||
| style="background: #F5F5F5; padding: 5px;" | -/+([[Carcinoid Tumor|Carcinoid tumor]]<nowiki/>s) | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* [[Anemia]] | * [[Anemia]] | ||
* Positive | * Positive<br>fecal<br>occult<br>blood<br>test | ||
* High levels of [[CEA]] and [[CA 19-9]] | * High<br>levels<br>of<br>[[CEA]]<br>and<br>[[CA 19-9]] | ||
|luminal narrowing | | style="background: #F5F5F5; padding: 5px;" | | ||
| | *luminal<br>narrowing<br> | ||
* [[Tumor]] mass and the extension of [[tumor]] to other structures | *[[Intestinal]]<br>wall<br>thickening,<br> | ||
*[[Intussusception|Intus-<br>susception]],<br> | |||
*[[Bowel obstruction]],<br> | |||
*[[Metastases|Hepatic<br>metastases]], | |||
*Intestinal<br>perforation,<br> | |||
*[[Lymphadenopathy|Enlarged<br>lymph<br>nodes]] | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures | |||
* [[liver]], [[lung]] and [[brain]] [[Metastasis]] | * [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]] | ||
|Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. | | style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific. | ||
|PET scan, Endoscopy, Colonoscopy, | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|PET<br>scan]],<br>[[Endoscopy]],<br>[[Colonoscopy]], | ||
Barium enema | [[Lower gastrointestinal series|Barium enema]] | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
* Depends on the tumor type. | * Depends<br>on the<br>tumor<br>type.<br>You will<br>find more<br>information<br>[[Colorectal cancer differential diagnosis|here]] | ||
|- | |- | ||
| colspan="2" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma peritonei]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma]] | ||
|<nowiki>+</nowiki> | [[Pseudomyxoma peritonei differential diagnosis|peritonei]] | ||
|<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|< | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | |||
|Bloating | | style="background: #F5F5F5; padding: 5px;" |Bloating | ||
|<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
|<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
|[[Ascites]] | | style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | ||
Shifting dullness | [[Shifting dullness]] | ||
|<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| | * Nonspecific | ||
* | * Depends<br>on the<br>[[etiology]]<br>of the<br>disease | ||
* Depends on the etiology of the disease | | style="background: #F5F5F5; padding: 5px;" | | ||
| | * Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma]] <br>from other<br> causes of<br>[[peritonitis]]. | ||
* Low-attenuation | * Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>[[Magnetic resonance imaging|MRI]].<br>[[Magnetic resonance imaging|MRI]] has<br> better<br>sensitivity<br>in<br>detecting<br>[[ascites]]<br>fluid <br>and<br>[[mucocele]]. | |||
* Typically does not invade visceral organs or spread by [[lymphatic]] or | | style="background: #F5F5F5; padding: 5px;" | | ||
| | * The echoes<br>within<br>[[Pseudomyxoma peritonei|pseudo-<br>myxoma <br>peritonei]] <br>are not <br>mobile. | ||
* Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites. | |||
| | * Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins | ||
* The echoes within | | style="background: #F5F5F5; padding: 5px;" |18F-FDG<br> [[PET scan]] | ||
* Echogenic septations within the gelatinous ascites. | | style="background: #F5F5F5; padding: 5px;" | | ||
* Scalloping of the [[hepatic]] and splenic margins | * Depending<br> on<br> [[WHO]]<nowiki/> <br>classification,<br> whether it is <br>low or high <br>grade<br> with <br>cellular atypia <br>or acellular mucin. <br>( DPAM, PMCA) | ||
|18F-FDG [[PET scan]] | * Gelatinous<br> [[ascites]] <br>in peritoneum <br>and<br> [[visceral]]<br><nowiki/>organs,<br>usually <br>underneath<br> the right<br> hemidiaphragm,<br> liver. | ||
| | |||
* Depending on [[WHO]]<nowiki/>classification, whether it | |||
* Gelatinous [[ascites]] in peritoneum and [[visceral]]<nowiki/>organs,usually underneath the right hemidiaphragm, liver. | |||
* Omental cake | * Omental cake | ||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
*CK 20 | |||
* [[CDX2]] | |||
* [[MUC2]] | |||
* MUC5AC | |||
|- | |- | ||
| colspan="2" |Carcinoid syndrome | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]] | ||
|<nowiki>-/+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-/+</nowiki> | ||
|<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
|<nowiki> | | style="background: #F5F5F5; padding: 5px;" |<math>\uparrow</math> | ||
|<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" | | ||
| | * [[Flushing]] | ||
* [[Palpitation]] | |||
* [[Dyspnea]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
** [[Tricuspid regurgitation|TR]][[Heart murmur|murmur]] | |||
** [[Wheeze|Wheezing]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | |||
| | | style="background: #F5F5F5; padding: 5px;" |Depends<br>on the<br>tumor<br>[[Neuroendocrine tumors laboratory findings|type]]: | ||
|<nowiki> | |||
| | |||
|< | |||
* Ki67 | * Ki67 | ||
* N-terminal pro–B-type natriuretic peptide | * N-terminal<br>pro–B-<br>type<br>natriuretic<br>peptide | ||
* [[Substance P]] | * [[Substance P]] | ||
* [[Neurotensin]] | * [[Neurotensin]] | ||
* [[Bradykinin]] | * [[Bradykinin]] | ||
* | * Human<br>chorionic<br>gonadotropin | ||
* | * Neuro-<br>peptide L | ||
* | * Pancreatic<br>polypeptide | ||
* | * | ||
| | | colspan="3" style="background: #F5F5F5; padding: 5px;" |Depends on the <br>primary tumor location and type | ||
|Depends on the primary tumor location and type | | style="background: #F5F5F5; padding: 5px;" | | ||
| | * [[Somatostatin]]<br>[[scintigraphy]]<br>with<br>111-indium-<br>octreotide | ||
| | * [[Bone]]<br>[[scintigraphy]]<br>with 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP) | ||
* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | * Positron<br>emission<br>tomography<br>(PET) | ||
* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP) | * 123I-MIBG<br> scintigraphy | ||
* | * [[Capsule endoscopy]]<br>(CE) | ||
* 123I-MIBG scintigraphy | |||
* [[Capsule endoscopy]] (CE) | |||
* [[Enteroscopy]] | * [[Enteroscopy]] | ||
* Angiography | * Angiography | ||
* | * MR Angiography | ||
* [[Endoscopic]] [[ultrasonography]] (EUS) | * [[Endoscopic]]<br>[[ultrasonography]] (EUS) | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
* Salt and pepper nuclei | * Salt<br> and<br> pepper<br> nuclei | ||
* Cellular uniformity | * Cellular<br> uniformity | ||
* Central ovoid nucleus | * Central <br>ovoid<br> nucleus | ||
* Presence of ribbons, trabeculae, nesting, glands, gyriform, pseudorosettes | * Presence of <br>ribbons,<br> trabeculae, <br>nesting, <br>glands,<br> gyriform,<br> pseudorosettes | ||
* Insulinoma (Amyloid deposition) | * Insulinoma <br>(Amyloid <br>deposition) | ||
* Somatostatinom (Psammoma bodies) | * Somatostatinom <br>(Psammoma <br>bodies) | ||
* Hyaline globules | * Hyaline <br>globules | ||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
* Synaptophysin <br>(almost<br> always, <br>strongly <br>and <br>diffusely<br> expressed ) | |||
* | * CGA | ||
* CD56 and PGP<br>( less <br>specific) | |||
** | * PDX1 | ||
* ISL1 | |||
|- | |- | ||
| colspan="2" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup> | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup> | ||
| | | style="background: #F5F5F5; padding: 5px;" | PU,<br>RLQ | ||
|<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
|< | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea<br> &<br>vomiting]],<br>decreased | |||
[[appetite]] | |||
|[[Nausea and vomiting|Nausea & vomiting]],[[ | |||
|<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
|<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Rebound<br>tenderness | ||
* | * Abdominal<br>guarding | ||
* [[Rovsing's sign]] | * [[Rovsing's sign|Rovsing's<br>sign]] | ||
* [[Psoas sign]] | * [[Psoas sign|Psoas<br>sign]] | ||
* [[Obturator sign]] | * [[Obturator sign|Obturator<br>sign]] | ||
* TR exam might reveal tenderness in the [[rectovesical pouch]] | * [[Rectal examination|TR exam]]<br>might reveal<br>tenderness<br>in the<br>[[Rectovesical excavation|rectovesical<br>pouch]] | ||
* [[Tachypnea]] | * [[Tachypnea]] | ||
* Tachycardia | * Tachycardia | ||
Line 391: | Line 583: | ||
* [[Diaphoresis]] | * [[Diaphoresis]] | ||
* [[Pallor]] | * [[Pallor]] | ||
|<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
* Left shift | * [[Left shift]] | ||
|Appendiceal wall thickening /perforation | | style="background: #F5F5F5; padding: 5px;" | | ||
*Appendiceal<br> wall<br> thickening<br> /perforation | |||
*Peri-<br>appendiceal<br>[[inflammation]],<br>fluid<br>accumulation,<br> | |||
*Fat<br>stranding | |||
| style="background: #F5F5F5; padding: 5px;" |Increased<br> fluid<br> signal <br> on T2 <br> weighted <br> sequence | |||
| style="background: #F5F5F5; padding: 5px;" |Evidences<br> of<br> [[inflammation]] | |||
* Dilated<br> appendix | |||
* Peri-<br>appendiceal <br> fluid<br> collection | |||
* Distinct <br> [[Vermiform appendix|appendix]]<br> wall<br> layers | |||
| style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] <br> labeled <br> anti-<br> [[CD15]]<br> [[antibodies]] | |||
| style="background: #F5F5F5; padding: 5px;" |Evidences <br> of<br> [[inflammation]] | |||
|- | |||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | |||
frequ- | |||
f | |||
ency | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | |||
'''symptoms''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> mass | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
physical | |||
exami- | |||
nation | |||
findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | |||
sounography | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
diagnostic | |||
studies | |||
and | |||
imaging | |||
modalities | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | |||
pathology | |||
|- | |||
|} | |} | ||
<small><sup>1</sup></small> | <small><sup>1</sup></small> [[Adenocarcinoma]]<nowiki/>s usually present with appendicitis, barely they might present with [[Pseudomyxoma peritonei]]; meanwhile [[pseudomyxoma peritonei]] is more prevalent in perforated [[mucocele]], goblet cell tumor or high stages of [[Adenocarcinoma|adenocarcinoma.]] | ||
<sup>2</sup> Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to | <sup>2</sup> Generally [[Vermiform appendix|appendix]] [[Carcinoid Tumor|carcinoids]] are [[asymptomatic]], they were only become symptomatic if they [[Liver mass|metastasize to the liver,]] or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendicea[[Adenocarcinoma|l adenocarcinoma]]. Any patient with [[carcinoid syndrome]] should be evaluated for [[Carcinoid|appendix carcinoid]]<nowiki/>s. | ||
<sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | <sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | ||
<sup>4</sup> '''[[Imaging]]''' '''is not a reliable method to''' '''distinguish between [[Cancer|neoplastic]] and''' '''[[Neoplasm|non-neoplastic]] lesions''', hence every patient should undergo [[surgery]], appendectomy and [[Histopathology|histopathologic]] evaluation of the lesion | |||
<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, [[Alpha-fetoprotein|AFP]]: [[Alpha-fetoprotein]], [[Human chorionic gonadotropin|HCG: Human chorionic gonadotropin]], [[Lactate dehydrogenase|LDH: Lactate Dehydrogenase]], [[Carcinoembryonic antigen|CEA: Carcinoembryonic antigen]], [[CA-125|CA-125: Cancer antigen 125]], [[5-Hydroxyindoleacetic acid|5-HIAA: Urinary 5-hydroxyindoleacetic acid]] , [[Chromogranin A|CgA: Serum Chromogranin A]] ,PU: Periumbelical, TR: [[Tricuspid regurgitation]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Surgery]] | |||
[[Category:Medicine]] | |||
[[Category:Emergency medicine]] | |||
[[Category: | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Differential diagnosis]] |
Latest revision as of 13:26, 15 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
Differentiating appendix cancer from other Diseases
- Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
- As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype.
- Carcinoid tumors must be differentiated from other diseases that cause carcinoid syndrome sign and symptoms such as palpitation, facial flushing, and diarrhea.
- In contrast, adenocarcinomas and cystadenocarcinomas must be differentiated from other diseases that cause acute appendicitis or present with pseudomyxoma peritonei, such as colorectal cancers and appendix mucoceles.
Diseases | Clinical manifestations | Para-clinical findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histo-
pathology | |||||||||||||
Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities | |||
Appendix cancer | Adeno- | +/- | -/+ | <math>\downarrow</math> |
|
- | - | - |
|
|
|
Positron emission tomography (PET) |
Gross pathology:
Microscopic
IHC:
| ||
Carcinoid | +/- | - | <math>\uparrow</math> |
|
- | - | + |
Ki67: |
|
Gross pathology:
Microscopic
IHC:
| |||||
Goblet
cell carcinoid |
+ | +/- | <math>\uparrow</math> |
|
+/- | + |
|
+/- |
|
Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate. |
Gross
Microscopic
| ||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology | |
Appendix Mucocele | Mucosal | - | - | - |
|
- | +/- | N/A | - | N/A |
|
Rounded right iliac fossa mass
|
|
N/A | Similar to hyperplastic colon polyp |
Simple
or |
- | - | - | - | +/- | - | - | N/A | Degenerative epithelial changes because of obstruction | ||||||
Mucinous cyst-
adenomas |
+/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+/- | +/- | If develop | - |
| ||||||
Mucinous cystadeno- | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> | +/- | +/- | - | - |
| |||||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra- sounography |
Other diagnostic studies and imaging modalities |
Histo-
pathology | |
Ovarian cancer | +/- | +/- | +/-<math>\downarrow</math> |
|
+ | +/- | - |
|
|
|
N/A | Depends on the tumor type. You may find the details here. | |||
Colorectal cancer | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+ | +/- | Colonoscopy
Carcinoids
|
-/+(Carcinoid tumors) |
|
Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. |
PET scan, Endoscopy, Colonoscopy, |
| |||
Pseudomyxoma | + | + | <math>\uparrow</math><math>\downarrow</math> | Bloating | - | + | Ascites | - |
|
|
Charact- |
|
18F-FDG PET scan |
IHC: | |
Carcinoid syndrome | -/+ | - | <math>\uparrow</math> | - | - | + | Depends on the tumor type:
|
Depends on the primary tumor location and type |
|
IHC:
| |||||
Appendicitis 3 | PU, RLQ |
- | <math>\uparrow</math><math>\downarrow</math> | Nausea & vomiting, decreased |
+/- | + |
|
- |
|
Increased fluid signal on T2 weighted sequence |
Evidences of inflammation
|
Tc-99m labeled anti- CD15 antibodies |
Evidences of inflammation | ||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
frequ- f ency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology |
1 Adenocarcinomas usually present with appendicitis, barely they might present with Pseudomyxoma peritonei; meanwhile pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.
2 Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma. Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.
3 Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.
4 Imaging is not a reliable method to distinguish between neoplastic and non-neoplastic lesions, hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion
*Abbreviations: RLQ: Right Lower Quadrant, AFP: Alpha-fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA-125: Cancer antigen 125, 5-HIAA: Urinary 5-hydroxyindoleacetic acid , CgA: Serum Chromogranin A ,PU: Periumbelical, TR: Tricuspid regurgitation